• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is selective laser trabeculoplasty shifting the glaucoma treatment paradigm in developing countries?

作者信息

Konstantakopoulou Evgenia, Gazzard Gus

机构信息

Glaucoma Department, Moorfields Eye Hospital NHS Foundation Trust, London, UK.

NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK

出版信息

Br J Ophthalmol. 2022 Sep;106(9):1185-1186. doi: 10.1136/bjophthalmol-2022-321706. Epub 2022 May 13.

DOI:10.1136/bjophthalmol-2022-321706
PMID:35568384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9411884/
Abstract
摘要

相似文献

1
Is selective laser trabeculoplasty shifting the glaucoma treatment paradigm in developing countries?选择性激光小梁成形术是否正在改变发展中国家青光眼的治疗模式？
Br J Ophthalmol. 2022 Sep;106(9):1185-1186. doi: 10.1136/bjophthalmol-2022-321706. Epub 2022 May 13.
2
Using the LiGHT study to adapt a glaucoma service for primary selective laser trabeculoplasty treatment.利用LiGHT研究对青光眼服务进行调整，以开展原发性选择性激光小梁成形术治疗。
Eye (Lond). 2020 Jun;34(6):1151-1152. doi: 10.1038/s41433-019-0659-9. Epub 2019 Nov 6.
3
Developments in laser trabeculoplasty.激光小梁成形术的进展
Br J Ophthalmol. 2016 Jan;100(1):94-7. doi: 10.1136/bjophthalmol-2015-307515. Epub 2015 Sep 16.
4
An Exploratory Retrospective Data Analysis Comparing the Outcomes of Selective Laser Trabeculoplasty and Argon Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension in Vienna, Austria, from the Year 2012 to 2022.一项探索性回顾性数据分析，比较了 2012 年至 2022 年在奥地利维也纳的开角型青光眼或高眼压症患者中选择性激光小梁成形术和氩激光小梁成形术的疗效。
Medicina (Kaunas). 2023 Nov 24;59(12):2075. doi: 10.3390/medicina59122075.
5
Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients.选择性激光小梁成形术作为药物控制的青光眼患者的替代治疗。
Acta Ophthalmol. 2018 Aug;96(5):e577-e581. doi: 10.1111/aos.13509. Epub 2017 Jun 21.
6
[Selective laser trabeculoplasty in glaucoma treatment--results during three years follow-up].[选择性激光小梁成形术治疗青光眼——三年随访结果]
Cesk Slov Oftalmol. 2010 Nov;66(5):204-8.
7
A Worldwide Price Comparison of Glaucoma Medications, Laser Trabeculoplasty, and Trabeculectomy Surgery.全球青光眼药物、激光小梁成形术和小梁切除术的价格比较。
JAMA Ophthalmol. 2018 Nov 1;136(11):1271-1279. doi: 10.1001/jamaophthalmol.2018.3672.
8
Educational intervention to adopt selective laser trabeculoplasty as first-line glaucoma treatment: Randomized controlled trial: Educational intervention on selective laser trabeculoplasty.将选择性激光小梁成形术作为青光眼一线治疗方法的教育干预：随机对照试验：关于选择性激光小梁成形术的教育干预
Eur J Ophthalmol. 2022 May;32(3):1538-1546. doi: 10.1177/11206721211018365. Epub 2021 May 27.
9
Comparative study of the efficacy of selective laser trabeculoplasty as initial or adjunctive treatment for primary open-angle glaucoma.选择性激光小梁成形术作为原发性开角型青光眼初始治疗或辅助治疗的疗效比较研究
Eur J Ophthalmol. 2019 Sep;29(5):524-531. doi: 10.1177/1120672118801129. Epub 2018 Sep 19.
10
Comparison of the short-term results of nasal and temporal 180° selective laser trabeculoplasties for open-angle glaucoma.比较鼻侧和颞侧 180°选择性激光小梁成形术治疗开角型青光眼的短期疗效。
Arq Bras Oftalmol. 2023 May-Jun;86(3):217-222. doi: 10.5935/0004-2749.20230044.

引用本文的文献

1
Safety and efficacy of laser trabeculoplasty compared to drug therapy for the management of open-angle glaucoma: systematic review and meta-analysis study.与药物治疗相比，激光小梁成形术治疗开角型青光眼的安全性和有效性：系统评价和荟萃分析研究
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):625-635. doi: 10.1007/s00417-024-06624-5. Epub 2024 Sep 19.

本文引用的文献

1
Glaucoma Cascade Screening in a High Risk Afro-Caribbean Haitian Population: A Pilot Study.高危非裔加勒比海地人群的青光眼级联筛查：一项试点研究。
J Glaucoma. 2022 Jul 1;31(7):584-589. doi: 10.1097/IJG.0000000000001996. Epub 2022 Feb 8.
2
COVID-19 and the Rationale for Primary Selective Laser Trabeculoplasty and Diode Laser Transscleral Cyclophotocoagulation in Africa.COVID-19 与在非洲行初级选择性激光小梁成形术和二极管激光经巩膜睫状体光凝术的基本原理
J Glaucoma. 2022 Apr 1;31(4):215-217. doi: 10.1097/IJG.0000000000001997.
3
European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition.欧洲青光眼学会青光眼术语和指南，第 5 版。
Br J Ophthalmol. 2021 Jun;105(Suppl 1):1-169. doi: 10.1136/bjophthalmol-2021-egsguidelines.
4
Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial.坦桑尼亚选择性激光小梁成形术与0.5%噻吗洛尔滴眼液治疗青光眼的随机对照试验
Lancet Glob Health. 2021 Nov;9(11):e1589-e1599. doi: 10.1016/S2214-109X(21)00348-X. Epub 2021 Oct 13.
5
Direct selective laser trabeculoplasty in open angle glaucoma study design: a multicentre, randomised, controlled, investigator-masked trial (GLAUrious).直接选择性激光小梁成形术治疗开角型青光眼的研究设计：一项多中心、随机、对照、研究者盲法试验（GLAUrious）。
Br J Ophthalmol. 2023 Jan;107(1):62-65. doi: 10.1136/bjophthalmol-2021-319379. Epub 2021 Aug 25.
6
Effectiveness of community outreach screening for glaucoma in improving equity and access to eye care in Nigeria.社区外展筛查青光眼对改善尼日利亚眼科保健公平性和可及性的效果。
Br J Ophthalmol. 2023 Jan;107(1):30-36. doi: 10.1136/bjophthalmol-2021-319355. Epub 2021 Aug 6.
7
Automated Direct Selective Laser Trabeculoplasty: First Prospective Clinical Trial.自动化直接选择性激光小梁成形术：首个前瞻性临床试验。
Transl Vis Sci Technol. 2021 Mar 1;10(3):5. doi: 10.1167/tvst.10.3.5.
8
Clinical outcomes following selective laser trabeculoplasty in Afro-Caribbean patients with glaucoma at high risk for progression.在有进展高危风险的非裔加勒比青光眼患者中施行选择性激光小梁成形术的临床转归。
Br J Ophthalmol. 2022 Sep;106(9):1235-1239. doi: 10.1136/bjophthalmol-2020-317117. Epub 2021 Apr 9.
9
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020.《柳叶刀》全球眼健康委员会：2020年之后的愿景。
Lancet Glob Health. 2021 Apr;9(4):e489-e551. doi: 10.1016/S2214-109X(20)30488-5. Epub 2021 Feb 16.
10
Low-energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial.每年重复低能量选择性激光小梁成形术：COAST 试验的原理。
J Glaucoma. 2021 Jul 1;30(7):545-551. doi: 10.1097/IJG.0000000000001788.